key: cord-0292485-ie41xmo0 authors: Gebara, Natalia; Scheel, Julia; Skovronova, Renata; Grange, Cristina; Marozio, Luca; Gupta, Shailendra; Giorgione, Veronica; Caicci, Federico; Benedetto, Chiara; Khalil, Asma; Bussolati, Benedetta title: Single extracellular vesicle analysis in human amniotic fluid shows evidence of phenotype alterations in preeclampsia date: 2022-02-14 journal: bioRxiv DOI: 10.1101/2022.02.14.480331 sha: ee2d24695ca5a43364be39c102d3ff21f6267caa doc_id: 292485 cord_uid: ie41xmo0 Amniotic fluid surrounding the developing fetus is a complex biological fluid rich in metabolically active bio-factors. The presence of extracellular vesicles (EVs) in amniotic fluid has been mainly related to fetal urine. We here characterized EVs from term amniotic fluid in terms of surface marker expression using different orthogonal techniques. EVs appeared to be a heterogeneous population expressing markers of renal, placental, epithelial and stem cells. Moreover, we compared amniotic fluid EVs from normal pregnancies with those of preeclampsia, a hypertensive disorder affecting up to 8% of pregnancies worldwide. An increase of CD105 (endoglin) expressing EVs was observed in preeclamptic amniotic fluid by bead-based cytofluorimetric analysis, and further confirmed using a chip-based analysis. HLA-G, a typical placental marker, was not co-expressed by the majority of CD105+ EVs, suggesting their origin from amniotic fluid cells. At a functional level, preeclampsia-derived EVs, but not normal pregnancy EVs, showed an antiangiogenic effect, possibly due to the decoy effect of endoglin. In addition, several miRNAs were differentially expressed in preeclampsia-derived EVs and directly related to the modulation of angiogenesis and trophoblast function. Our results provide a characterization of term amniotic fluid-EVs, supporting their origin from fetal and placental cells. In preeclampsia, the observed antiangiogenic characteristics of amniotic fluid-EVs may reflect the hypoxic and antiangiogenic microenvironment and could possibly impact on the developing fetus or on the surrounding fetal membranes. Amniotic fluid is a complex biological fluid surrounding the developing fetus and in close 50 proximity to the placenta (Underwood, Gilbert and Sherman, 2005) . Its composition, after fetal 51 skin keratinization, mainly consists of fetal cardiovascular, renal, pulmonary, and endothelial 52 secretions (Roubelakis, Trohatou and Anagnou, 2012) . Amniotic fluid has a relevant role in 53 fetal physiology; it not only acts as a protective cushion to mechanical injury but also contains 54 a plethora of active factors, including nutrients, growth and antimicrobial factors, cells and 55 extracellular vesicles (EVs) (Underwood, Gilbert and Sherman, 2005) . 56 EVs are a highly heterogeneous population of small particles enclosed in a lipid bilayer, 57 released by almost all cell types, and involved in cell-to-cell signalling. In pregnancy, EVs are 58 essential for diverse physiological and pathological processes (Jankovičová et al., 2020) and 59 may play a role in angiogenesis and successful fetal development (Gebara et al., 2021) . The 60 role of EVs derived from placental trophoblasts has been studied extensively, as they are 61 continuously released into the maternal bloodstream and play a crucial role in regulating the 62 maternal immune response and pregnancy adaptation (Nair and Salomon, 2018) . At variance, 63 the profile and function of EVs present in amniotic fluid have been poorly investigated, as their 64 characteristics have been mainly attributed to fetal urine production (Keller et al., 2007) . 65 Indeed, previous studies showed that a large proportion of EVs within the amniotic fluid 66 express typical renal markers, such as aquaporin-2 and CD24, demonstrating their fetal urine 67 origin (Keller et al., 2007) . However, multiple cells may release EVs into the amniotic fluid, 68 including the amnion, placental tissues and fetal cells (Dixon et al., 2018; McMaster et al., 69 1998) . Interestingly, isolated amniotic epithelial or stem cells in culture were shown to release 70 EVs with trophic, immunomodulating and anti-inflammatory functions (Balbi et al., 2017; 71 Sedrakyan et al., 2017) . It is therefore conceivable that EVs released from those cells are also 72 present in the amniotic fluid. Moreover, a recent trial reported the safe administration of a 73 AFSCs were previously obtained and characterized, as described (Iampietro et al., 2020) . AFSCs expressed typical mesenchymal surface markers and 133 differentiation properties, as previously described (Iampietro et al., 2020) . 134 EV Isolation from amniotic fluid: Amniotic fluid samples were diluted in PBS up to a volume 135 of 20 ml and subjected to differential centrifugations. For the isolation of cells, samples 136 underwent a 5 min centrifugation at 300 x g, at room temperature. A second centrifugation of 137 10 min was performed at 500 x g, at room temperature, for removal of debris. The supernatant 138 was then passed through a cell sieve and underwent a 30 min ultracentrifugation (70 Ti rotor, 139 Beckman Coulter, CA, USA) at 10,000 x g, at 4°C. The resulting pellet was discarded, and the 140 supernatant was further centrifuged for 2 h at 100,000 x g at 4°C. The final step included 141 resuspension of EV pellets in 1 ml 1% DMSO/PBS and additional filtration through a 0.22 µm 142 filter. The recovered EVs were stored at -80°C. 143 EV Isolation from AFSCs: The term AFSCs were grown to 70-80% confluency, washed twice 144 with PBS and placed in serum free RPMI medium overnight. After 16 h of incubation, the 145 RPMI medium was recovered and centrifuged at 300 x g for 5 min, 10,000 x g for 30 min, 146 followed by ultracentrifugation at 100,000 x g for 2 h at 4°C. Table 1 ) and miScript 277 SYBR Green PCR Kit (Qiagen, Hilden, Germany). RNA U6 was used as the endogenous 278 control. The samples were analysed using the comparative CT method. In total 20 miRNAs 279 were selected and validated, based on literature research via Pubmed interrogation with the 280 following keywords: "miRNAx" and "angiogenesis or placenta or pre-eclampsia" or 281 "miRNAx" and "angiogenesis or placenta or pre-eclampsia" and extracellular vesicles". EVs were isolated from term amniotic fluid of 40 normal pregnancies (Table 1) In addition, super-resolution microscopy was used to analyze the size and expression of 348 tetraspanin markers (CD63, CD81 and CD9) at a single-molecule level in NP-EVs (Figure 2) . 349 The results showed that NP-EVs were a heterogeneous population with highly variable 350 tetraspanin expression ( Figure 2E ). The analysis of more than 20,000 EVs using a dedicated 351 software (https://alto.codi.bio/) showed that the majority of EVs were either triple positive for 352 CD63, CD81 and CD9 or double positive for CD81 and CD9, with lower fractions expressing 353 double or single tetraspanins ( Figure 2E ). The overall average particle size evaluated by the 354 super-resolution microscope was 121±26 nm. This measurement, based on specific EV 355 detection using tetraspanins, overlaps the results obtained by transmission electron microscopy. EVs were also isolated from term-amniotic fluid of 7 preeclamptic pregnancies ( Table 1) . The 378 different volumes and EV concentrations in each sample are reported in Supplementary Table 379 1. No difference in mean EV concentration between NP-EVs and PE-EVs (2.85x10 9 and 380 2.17x10 9 particles/ml, respectively) was observed, although the relevance of this parameter is 381 ExoView analysis was subsequently used to assess at single-EV level the expression of NP-396 EV and PE-EV surface markers of interest. After EV affinity binding to tetraspanins, CD105, 397 Tie-2, CD117 (c-kit) and HLA-G expression were evaluated on captured EVs ( Figure 3C ). The 398 analysis confirmed the presence of HLA-G, as shown by super-resolution microscopy, and 399 revealed the presence of the angiogenic marker Tie-2 and of the stem cell marker CD117 on 400 both NP-and PE-EVs. In addition, the analysis confirmed the increased expression of CD105 401 in PE-EVs with respect to NP-EVs ( Figure 3C ). By simultaneously detecting HLA-G along 402 with the other makers, we were able to assess their co-expression. The analysis showed that 403 the HLA-G expressing EVs displayed similar CD105 and c-kit markers levels, suggesting that 404 the increased CD105 expressing EVs present in PE were not of placental origin ( Figure 3D) . 405 At variance, Tie-2 levels were significantly lower in placental EVs of PE pregnancies. No 406 differences in tetraspanin levels, used as control, were observed (Supplementary Figure 1B) . 407 The increased CD105 expression in PE-EVs with respect to NP-EVs was also confirmed by Soluble endoglin is a differentially spliced form of endoglin and is a relevant antiangiogenic 442 factor in PE, acting as a decoy receptor for transforming growth factor beta (TGF-β) (Valluru 443 et al., 2011) . To test the angiogenic properties of NP-EVs, PE-EVs, and the possible role of 444 CD105 increased expression on the EV surface, a tube formation assay was performed. Moreover, based on surface marker expression as well as miRNA content, we found that EVs 523 within the term amniotic fluid may originate from various sources. Indeed, amniotic fluid-EVs 524 expressing CD24 were mainly derived from fetal urine (Keller et al., 2007) . In this study, we 525 confirmed the possible cellular origin of the EVs attributed to fetal urine by expression not only 526 of CD24 but also of CD133, which is also considered to be highly present in urinary EVs 527 (Dimuccio et al., 2014) . Additionally, amniotic fluid-EVs expressed mesenchymal and stem 528 markers, possibly suggesting the origin from CD117 + amniotic fluid stem cells (Cananzi, Atala 529 and De Coppi, 2009), amniotic CD105 + mesenchymal stem cells (Baghaei et al., 2017) , and 530 SSEA-4 + expressing embryonic stem cells (Noisa et al., 2012) . Interestingly, we also showed 531 that a large fraction of amniotic NP-EVs expressed HLA-G, as detected by ExoView and super-532 The increased CD105 level in PE-EVs is in agreement with previous data, showing higher 567 levels of endoglin on EVs produced by placental explants treated with preeclamptic sera 568 (Tannetta et al., 2013) and support the concept that surface receptors expressed by EVs may 569 act as a decoy for soluble factors (Tannetta et al., 2013; Sedrakyan et al., 2017) . In analogy, 570 we found that PE-EVs affected angiogenesis in vitro and that this effect was abolished when 571 CD105 was blocked by a specific antibody. A slight antiangiogenic effect was also observed 572 for NP-EVs, in parallel with data showing that AFSC-EVs do not promote angiogenesis despite 573 their regenerative effect (Takov et al., 2020) . However, this was not prevented by the anti-574 CD105 antibody, suggesting the involvement of other factors. Previous data showed that 575 administration of human EVs derived from preeclamptic placentas in mice resulted in damage 576 to the vasculature, poor fetal nutrition and promoted endothelial permeability and glomeruli 577 damage (Chang et al., 2018) . In particular, the study provided an additional mechanism for the 578 antiangiogenic effect of EVs, related to the presence of soluble endoglin transfer from the EV 579 Preeclampsia: Long-term consequences for vascular health Isolation, differentiation, and characterization of mesenchymal 631 stem cells from human bone marrow', Gastroenterology and Hepatology from Bed to Bench Downregulated miR-195 detected in Preeclamptic Placenta affects 634 trophoblast cell invasion via modulating ActRIIA expression First characterization of human amniotic fluid stem cell extracellular 637 vesicles as a powerful paracrine tool endowed with regenerative potential ClueGO: A Cytoscape plugin to decipher functionally grouped gene 640 ontology and pathway annotation networks Effect of the monoclonal antibody TRC105 in 643 combination with Sunitinib on renal tumor derived endothelial cells Hypertensive disorders of pregnancy: ISSHP classification, 646 diagnosis, and management recommendations for international practice Stem cells derived from amniotic fluid: New 649 potentials in regenerative medicine Exosomes from women with preeclampsia induced vascular 652 dysfunction by delivering sFLT (soluble fms-like tyrosine kinase)-1 and SENG (soluble 653 endoglin) to endothelial cells Enrichr: Interactive and collaborative HTML5 gene list enrichment 656 analysis tool MicroRNA expression profiles in placenta with severe preeclampsia 658 using a PNA-based microarray Syncytiotrophoblast derived extracellular vesicles transfer 661 functional placental miRNAs to primary human endothelial cells Oxidative Stress Alters miRNA and Gene Expression Profiles in 664 Urinary CD133+ extracellular vesicles are decreased in kidney 667 transplanted patients with slow graft function and vascular damage Amniotic fluid exosome proteomic profile exhibits unique 670 pathways of term and preterm labor The global impact of pre-eclampsia and eclampsia Role of extracellular vesicles and microRNAs on dysfunctional 675 angiogenesis during preeclamptic pregnancies Immunomodulatory molecules are released from the first 678 trimester and term placenta via exosomes Extracellular vesicle RNAs reflect placenta dysfunction and are a 681 biomarker source for preterm labour Angiogenic properties of placenta-derived extracellular vesicles in 684 normal pregnancy and in preeclampsia Maternal plasma miRNAs as biomarkers during mid-pregnancy to 687 predict later spontaneous preterm birth: A pilot study Single-vesicle imaging and colocalization analysis for tetraspanin 690 profiling of individual extracellular vesicles Cardiovascular and cerebrovascular disease associated 693 microRNAS are dysregulated in placental tissues affected with gestational hypertension, 694 preeclampsia and intrauterine growth restriction Differential expression of microRNAs in the placentae of Chinese 697 patients with severe pre-eclampsia MiRTarBase 2020: Updates to the experimentally validated 700 microRNA-target interaction database Full-Term Human Amniotic Fluid Mesenchymal Stem Cells Show 703 Nephroprotective Effect In An Acute Kidney Injury Model Tetraspanins, more than markers of extracellular vesicles in 706 reproduction The reactome pathway knowledgebase Endovascular trophoblast invasion: 711 Implications for the pathogenesis of intrauterine growth retardation and preeclampsia CD24 is a marker of exosomes secreted into urine and amniotic fluid Computational analysis of target hub gene repression regulated by 716 multiple and cooperative miRNAs BiNGO: a Cytoscape plugin to assess 719 overrepresentation of Gene Ontology categories in Biological Networks BisoGenet: A new tool for gene network building, visualization and 722 analysis Expression profile of microRNAs and mRNAs in human 724 placentas from pregnancies complicated by preeclampsia and preterm labor HLA-G isoforms produced by placental cytotrophoblasts and 727 found in amniotic fluid are due to unusual glycosylation Circulating exosomal miRNA profile during term and preterm birth 730 pregnancies: A longitudinal study Case Report: Administration of Amniotic Fluid-Derived 733 Nanoparticles in Three Severely Ill COVID-19 Patients Extracellular vesicle isolation methods: rising impact of 736 size-exclusion chromatography Size distribution of extracellular vesicles by optical correlation 739 techniques Molecular mechanisms of preeclampsia Placenta-Derived Exosomes and Syncytiotrophoblast Microparticles 743 and their Role in Human Reproduction: Immune Modulation for Pregnancy Success Extracellular vesicles and their immunomodulatory 746 functions in pregnancy Identification and Characterisation of the Early Differentiating Cells 749 in Neural Differentiation of Human Embryonic Stem Cells KEGG: Kyoto encyclopedia of genes and genomes Placental Release of Distinct DNA-associated Micro-particles 754 into Maternal Circulation: Reflective of Gestation Time and Preeclampsia MicroRNA-141 is upregulated in preeclamptic placentae and 757 regulates trophoblast invasion and intercellular communication Exosomal microRNA profiling in early and late onset preeclamptic 760 pregnant women reflects pathophysiology Amniotic fluid and amniotic 763 membrane stem cells: Marker discovery The harmonizome: a collection of processed datasets gathered 766 to serve and mine knowledge about genes and proteins', Database : the journal of biological 767 databases and curation Placental exosomes as early biomarker of preeclampsia: Potential 769 role of exosomalmicrornas across gestation Placental extracellular vesicles and pre-eclampsia Amniotic fluid stem cell-derived vesicles protect from VEGF-774 induced endothelial damage Cytoscape: A software Environment for integrated models of 777 biomolecular interaction networks Surface marker expression in small and medium/large 780 mesenchymal stromal cell-derived extracellular vesicles in naïve or apoptotic condition using 781 orthogonal techniques Circulating concentrations of soluble endoglin (CD105) in fetal and 783 maternal serum and in amniotic fluid in preeclampsia Small extracellular vesicles secreted from human amniotic fluid 786 mesenchymal stromal cells possess cardioprotective and promigratory potential', Basic 787 Research in Cardiology Characterisation of Syncytiotrophoblast Vesicles in Normal 789 Pregnancy and Pre-Eclampsia: Expression of Flt-1 and Endoglin Minimal information for studies of extracellular vesicles 2018 792 (MISEV2018): a position statement of the International Society for Extracellular Vesicles 793 and update of the MISEV2014 guidelines TransmiR v2.0: An updated transcription factor-microRNA regulation 796 database Amniotic fluid: Not just fetal 798 urine anymore Transforming growth factor-β and endoglin signaling orchestrate 800 wound healing We thank Dr. Sharad Kholia for his help with the figure and manuscript editing and correction. 618